|
|
|
| Application Value of Docetaxel and Cisplatin Combined with Tislelizumab in Patients with Advanced NSCLC |
| CAO Yanyan, ZHAN Tao, WU Chao |
| First-author's address: Department of Pharmacy and Medical Devices, Ganzhou Cancer Hospital, Ganzhou 341000, China |
|
|
|
|
|
|
Received: 08 January 2026
|
|
|
|
|
|
|
